Pliant Therapeutics

Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the development of integrin-based therapeutics. The company is focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases, diving deep to understand and apply the role of integrins in disease. By targeting the molecular drivers of fibrotic diseases, Pliant seeks to unlock potentially safer and more effective therapies for patients. The company's pipeline includes programs targeting a range of fibrotic conditions, with integrin inhibitors designed for tissue-specific activity. Pliant is led by world-renowned researchers and highly experienced drug developers and is committed to sustainable ESG practices. Its office and laboratory are located at 331 Oyster Point Blvd, South San Francisco, CA.